Aurobindo Pharma Limited (NSE: AUROPHARMA)
India
· Delayed Price · Currency is INR 1,171.30
+45.90 (4.08%)
Feb 4, 2025, 3:30 PM IST
Aurobindo Pharma Employees
Aurobindo Pharma had 26,015 employees as of March 31, 2024. The number of employees increased by 2,564 or 10.93% compared to the previous year.
Employees
26,015
Change (1Y)
2,564
Growth (1Y)
10.93%
Revenue / Employee
11.65M INR
Profits / Employee
1.38M INR
Market Cap
680.29B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 9,741 |
| Cipla | 27,764 |
| Mankind Pharma | 19,540 |
| Apollo Hospitals Enterprise | 83,147 |
| Zydus Lifesciences | 26,921 |
| Alkem Laboratories | 17,432 |
| Fortis Healthcare | 12,088 |
Aurobindo Pharma News
- 7 days ago - Aurobindo Pharma subsidiary’s facility receives EIR from US FDA with VAI classification - Business Upturn
- 12 days ago - Brokerage Report: CLSA expects India pharma market to grow at 8-9% in 2025, Dr. Reddy’s downgraded to ‘Underperform’, Aurobindo Pharma upgraded to ‘Outperform’ - Business Upturn
- 14 days ago - Pharma stocks: Glenmark up 1.57%, Glaxo gains 1.31%, Mankind Pharma declines 2.84% - Business Upturn
- 19 days ago - Pharma sector stocks: Biocon (+3.10%), Aurobindo Pharma (+0.48%), Divis Labs (+0.39%) rise; Mankind Pharma (-1.43%) leads losers - Business Upturn
- 27 days ago - Pharma stocks: Dr. Reddy’s up 1.70%, Biocon down 2.17%, Lupin falls 2.18% - Business Upturn
- 4 weeks ago - Pharma sector stocks performance: Ipca Labs gains 1.23%, Biocon up 0.84%, Sun Pharma and Torrent Pharma slip over 1% - Business Upturn
- 5 weeks ago - Aurobindo Pharma (+1.58%), Mankind Pharma (+1.48%), Zydus Lifesciences (+0.91%) lead pharma stock gains - Business Upturn
- 6 weeks ago - Aurobindo Pharma subsidiary gets approval for oncology biosimilar Bevqolva from UK’s MHRA - Business Upturn